With a market cap of $169.7 billion, Intuitive Surgical, Inc. (ISRG) designs, manufactures, and markets advanced robotic-assisted surgical systems and related products. The company also provides instruments, accessories, digital solutions, and comprehensive service support to enhance surgical precision and hospital performance worldwide.

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and Intuitive Surgical fits this criterion perfectly. Its flagship da Vinci Surgical System enables minimally invasive procedures, complemented by the Ion endoluminal system for diagnostic lung biopsies. 

Shares of the Sunnyvale, California-based company have pulled back 23.2% from its 52-week high of $616. ISRG stock has fallen 14.8% over the past three months, underperforming the broader S&P 500 Index’s ($SPX) 9.3% gain over the same time frame.

In the longer term, shares of Intuitive Surgical have decreased 1.9% over the past 52 weeks, lagging behind the 15.5% return of the SPX over the same time frame. Moreover, the stock is down 9.3% on a YTD basis, compared to SPX’s 9.8% rise.

Despite a few fluctuations, the stock has been trading below its 50-day and 200-day moving averages since early June. 

Shares of ISRG fell 1.8% following its Q2 2025 results on Jul. 22 despite beating expectations, as investor concerns focused on slowing international system placements, which declined to 179 due to budgetary pressures in Japan, China, and Europe. While Q2 sales rose 21% to $2.4 billion and adjusted EPS jumped 23% to $2.19, the cautious tone on global growth overshadowed these positives. 

However, rival Becton, Dickinson and Company (BDX) stock has shown a more pronounced decline than ISRG stock. BDX stock has dropped 14.9% on a YTD basis and 19.2% over the past 52 weeks. 

Despite the stock’s weak performance over the past year, analysts remain moderately optimistic about its prospects. ISRG stock has a consensus rating of “Moderate Buy” from 29 analysts in coverage, and the mean price target of $597.12 is a premium of 26.2% to current levels.